About 100 reports

  • Hypertension Drugs Industry Structure
  • Other Hypertension Drugs

Table ##: Economic Outlook Summary (Billion Yuan) Chart ##: Economic Outlook Summary (Billion Yuan) INTRODUCTION Chapter I THE CURRENT MARKET FOR HYPERTENSION DRUGS IN CHINA IS GROWING RAPIDLY.

  • Hypertension
  • China
  • Demand
  • AstraZeneca China Inc.
  • Sanofi-Synthelabo Inc.
  • Increase in incidence of pulmonary hypertension (PH)
  • 66 GLOBAL PULMONARY ARTERIAL HYPERTENSION DRUGS MARKET 2017-2021

According to the CDC, ## million Americans have high blood pressure, i. e., one in every three adults have symptoms of PAH.

  • Hypertension
  • Actelion Ltd
  • Daiichi Sankyo Company
  • Novartis AG
  • United Therapeutics Corporation
  • Other Hypertension Drugs
  • HYPERTENSION DRUGS EXPORT (MILLION YUAN)

Table ##: Economic Outlook Summary (Billion Yuan) Chart ##: Economic Outlook Summary (Billion Yuan) INTRODUCTION Chapter I The current market for Hypertension Drugs in China is growing rapidly.

  • Hypertension
  • China
  • Demand
  • Trade
  • AstraZeneca China Inc.
  • Systemic hypertension
  • PULMONARY ARTERIAL HYPERTENSION KEY METRICS IN THE 7MM

Prognostic factors in pulmonary arterial hypertension with Dana Point group ##.

  • Hypertension
  • United States
  • Forecast
  • Actelion Ltd
  • United Therapeutics Corporation
  • PATHOPHYSIOLOGY OF HYPERTENSION
  • Overview: Hypertension

PREHYPERTENSION ##-## Less than ## Systolic BP (mm Hg) Diastolic BP (mm Hg) Less than ## ##-## STAGE ## HYPERTENSION STAGE ## HYPERTENSION Greater than or equal to ## Greater than or equal to ## ##-## ##-## CLASSIFICATION OF HYPERTENSION Category NORMAL PATHO

  • Hypertension
  • Actelion Ltd
  • AstraZeneca PLC
  • Daiichi Sankyo Company
  • Sanofi S.A.
  • Pulmonary Arterial Hypertension: Executive Summary
  • 4.1 BIBLIOGRAPHY

Prognostic factors in pulmonary arterial hypertension with Dana Point group ##.

  • Hypertension
  • Germany
  • Japan
  • United States
  • Forecast
  • Hypertension Drugs Sales Volume
  • Hypertension Drugs Industry Structure

Table ##: Economic Outlook Summary (Billion Yuan) Chart ##: Economic Outlook Summary (Billion Yuan) INTRODUCTION Chapter I THE CURRENT MARKET FOR HYPERTENSION DRUGS IN CHINA IS GROWING RAPIDLY.

  • Hypertension
  • China
  • AstraZeneca China Inc.
  • Hangzhou MSD Pharmaceutical Co., Ltd
  • Sanofi-Synthelabo Inc.
  • Global pulmonary hypertension market: 2014-2019 ($ billions)
  • Strength

The drug prevents the binding of ET-## to both endothelin receptors, ET- A and B resulting in decreased hypertension.

  • Hypertension
  • United States
  • Actelion Ltd
  • Bayer AG
  • United Therapeutics Corporation

Global Hypertension Epidemiology and Patient Flow Analysis - 2017 ##.

  • Hypertension
  • France
  • United States
  • World
  • Forecast

Global Plumonary Arterial Hypertension Epidemiology and Patient Flow Analysis - 2017 ##.

  • Hypertension
  • France
  • United States
  • World
  • Forecast
  • Classification of hypertension
  • TOP-LINE PREVALENCE FOR HYPERTENSION

Table ##.

  • Chronic Disease
  • Hypertension
  • Pathology
  • ANTI-HYPERTENSIVE THERAPEUTICS, TREATMENT ALGORITHM OF HYPERTENSION
  • ANTI-HYPERTENSIVE THERAPEUTICS, DEFINITIONS OF HYPERTENSION BY OFFICE AND OUT-OF-

For example, SER-## is an opioid receptor like-## (ORL-##) agonist that failed in Phase II clinical trial in patients with isolated systolic hypertension.

  • Hypertension
  • Market Size
  • Daiichi Sankyo Company
  • Merck & Co., Inc.
  • Novartis AG

2018 Idiopathic Hypertension Drug Development Pipeline Analysis Report- Companies, Drugs, Clinical Trials, Latest Developments in Idiopathic Hypertension Market ## Table of Contents ##. ## List of Figures ##. ## List of Tables ## Idiopathic Hypertension Pipeline Analysis

  • Hypertension
  • Pharmaceutical

2018 Essential Hypertension Drug Development Pipeline Analysis Report- Companies, Drugs, Clinical Trials, Latest Developments in Essential Hypertension Market ## Table of Contents ##. ## List of Figures ##. ## List of Tables ## Essential Hypertension Pipeline Analysis ##. ##

  • Hypertension
  • Pharmaceutical
  • Increasing incidence of hypertension coupled with geriatric population
  • monitoring the person's blood pressure accurately. It is highly useful in evaluating white coat hypertension or masked hypertension.

High blood pressure leading to hypertension is one of the primary reason for heart diseases.

  • Blood Device
  • Hemodynamic Monitor
  • Hypertension
  • World
  • Forecast

Hypertension Phase ## Clinical Trials, 2016 ##.

  • Hypertension
  • France
  • United States
  • Market Shares
  • Market Size

Europe Hypertension Epidemiology and Patient Flow Analysis - 2017 ##.

  • Hypertension
  • Europe
  • France
  • Germany
  • Forecast

Pulmonary Hypertension Phase ## Clinical Trials, 2016 ##.

  • Hypertension
  • France
  • United States
  • Market Shares
  • Market Size

Europe Plumonary Arterial Hypertension Epidemiology and Patient Flow Analysis - 2017 ##.

  • Hypertension
  • Europe
  • France
  • Germany
  • Italy

Global Pulmonary Arterial Hypertension Epidemiology and Patient Flow Analysis - 2016 ##.

  • Hypertension
  • France
  • United States
  • World
  • Forecast
  • Increasing incidence of hypertension coupled with geriatric population
  • Identifying factors impacting market growth

High blood pressure leading to hypertension is one of primary reason for cardiovascular diseases.

  • Hemodynamic Monitor
  • Hypertension
  • World
  • Forecast
  • Omron Corporation

Hypertension Phase ## Clinical Trials, 2016 ##.

  • Hypertension
  • France
  • Germany
  • Market Shares
  • Market Size

Hypertension Phase ## Clinical Trials, 2016 ##.

  • Chronic Disease
  • Hypertension
  • Japan
  • Market Shares
  • Market Size

Hypertension Phase ## Clinical Trials, 2016 ##.

  • Chronic Disease
  • Hypertension
  • United States
  • Market Shares
  • Market Size

Hypertension Phase ## Clinical Trials, 2016 ##.

  • Chronic Disease
  • Hypertension
  • United Kingdom
  • Market Shares
  • Market Size

Hypertension Phase ## Clinical Trials, 2016 ##.

  • Chronic Disease
  • Hypertension
  • Italy
  • Market Shares
  • Market Size

Hypertension Phase ## Clinical Trials, 2016 ##.

  • Chronic Disease
  • Hypertension
  • Germany
  • Market Shares
  • Market Size

Hypertension Phase ## Clinical Trials, 2016 ##.

  • Chronic Disease
  • Hypertension
  • France
  • Market Shares
  • Market Size

Hypertension Phase ## Clinical Trials, 2016 ##.

  • Chronic Disease
  • Hypertension
  • Spain
  • Market Shares
  • Market Size

Pulmonary Hypertension Phase ## Clinical Trials, 2016 ##.

  • Hypertension
  • France
  • Germany
  • Market Shares
  • Market Size